AlphAIalphai — Financial news for AI agents
SEC EDGARSEP 21 min read$AMBQ

Esaka Fumihide sold $6.2M of AMBQ

Esaka Fumihide (Chief Executive Officer) sold 108,500 shares of Ambiq Micro, Inc. (AMBQ) at an average of $56.89 ($56.15–$58.52, $6.17M total) across 9 trades over 2026-08-31 to 2026-09-02 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Esaka Fumihide
Published Sep 2, 2026, 8:47 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Sep 2, 2026, 9:22 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefInsider activity
Primary signal
$AMBQ
Bearish
medium confidence
Mentioned
$AMBQ
Relevance
5/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AMBQBearishLow
01

Why it matters

The disclosure provides fresh data on insider sentiment, which can influence short‑term price dynamics.

02

Market read

Insider sales in micro‑caps often trigger short‑term price moves; traders may adjust positions accordingly.

03

What to watch

Recent product announcements or contract wins could offset the impact of the insider sale.

Relevance 5/10Novelty 7/10Timing: post‑market filing on 2026‑09‑02

Background

SEC Form 4 filing discloses insider transactions; this is the first public report of the CEO's sale.

Company-level read

Ticker impact

$AMBQBearishMedium confidence
Context

CEO Esaka Fumihide sold 108,500 shares for $6.17M via a 10b5‑1 plan, reducing his stake to 460,460 shares.

Expected impact

Potential modest downside pressure over the next few trading sessions.

Evidence & confidence

A $6M sale by the chief executive is material for a micro‑cap, but the 10b5‑1 plan suggests pre‑planned execution rather than panic.

Market effects

Sector

Minimal; insider activity is specific to Ambiq Micro and does not affect the broader semiconductor sector.

Regional

None; the filing is U.S.‑focused and does not influence regional markets.

Global

Low; only relevant to investors tracking micro‑cap AI‑chip stocks.

Counterpoint

What could challenge this read

The sale may be routine under a 10b5‑1 plan and not indicative of negative fundamentals; the stock could be undervalued.

Key entities

  • Company
    Ambiq Micro, Inc.

    U.S. listed semiconductor company (NASDAQ: AMBQ).

  • Executive
    Esaka Fumihide

    Chief Executive Officer of Ambiq Micro.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

AMBQ insider trading history →

Related articles

AUG 13
Med

Ambiq Micro, Inc. Q2 2026 Earnings Call Summary

Ambiq Micro reported Q2 2026 results and said revenue rose 90% year over year, driven by stronger Edge AI demand and growth across Apollo II and Apollo IV, with Apollo V more than doubling on a new large customer ramp. Management projected Q3 net sales up ~100% YoY and 2026 revenue about $135M, despite supply constraints limiting shipments. Gross margin expected to improve modestly in 2026.

yahoo.com4 min
AUG 12
Med

Ambiq Micro Q2 net loss narrows to US$7.1 million as edge AI sales surge

Ambiq Micro reported Q2 net loss of $7.1 million, or $0.32 per share, narrowing from $8.5 million a year earlier, as revenue rose 89.7% on stronger demand for ultra-low power edge AI chips. Q2 gross profit more than doubled to $15.3 million and gross margin rose to 45%. H1 net loss was $17.3 million. Cash was $366.8 million after a June follow-on raising $167.9 million net proceeds.

businesstimes.com.sg3 min
AUG 12
$AMBQHighAI 9/10

Ambiq (AMBQ) Q2 2026 Earnings Call Transcript

Ambiq Micro (AMBQ) reported Q2 2026 net sales of $33.9 million, up 89.7% year over year, citing accelerating edge AI demand. Non-GAAP gross margin was 47.2%. Full-year net sales guidance is about $135 million, with Q3 revenue outlook of $36 million to $37 million. Management cited supply constraints limiting order fulfillment and said cash was $366.8 million as of June 30, 2026.

fool.com6 min